Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/2480 stock hub

HKG/2480 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

HKG/2480is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
4.4B
Hong Kong Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
HKG/2480
In the news

Latest news · HKG/2480

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E38.4
P25 11.7P50 18.9P75 41.4
Trailing P/En/a
P25 10.7P50 17.9P75 38.5
ROE-19.9
P25 -14.7P50 2P75 9.4
ROIC-10.2
P25 -10.4P50 1.9P75 10.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All HKG/2480 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
141
Groups with data
11
Currency
CNY
Showing 141 of 141 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
China
Country code
HK
Employees
193
Employees Change
34%
Employees Change Percent
21.38
Enterprise value
HKD 4.2B
Exchange
Hong Kong Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Biotechnology
Last refreshed
2026-05-10
Market cap
HKD 4.4B
Price
HKD 22.08
Price currency
HKD
Sector
Healthcare
Sic
2836
Symbol
hkg/2480
Website
https://luzhubiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

6
MetricValue
Earnings Yield
-3.81%
EV Earnings
-25.28x
EV/FCF
-20.09x
FCF yield
-4.79%
Forward P/E
38.36x
P/B ratio
5.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

6
MetricValue
Net Income
HKD -167.3M
Profit Per Employee
HKD -866,925
ROA
-9.01
ROCE
-16.35
ROE
-19.87
ROIC
-10.15

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

1
MetricValue
Cagr1y
0.36%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Assets
HKD 1.2B
Cash
HKD 466.8M
Current Assets
HKD 505M
Current Liabilities
HKD 136.4M
Debt
HKD 303.8M
Debt Equity
HKD 0.41
Debt FCF
HKD -1.44
Equity
HKD 734.6M
Interest Coverage
-22.87
Liabilities
HKD 422.3M
Long Term Assets
HKD 651.9M
Long Term Liabilities
HKD 285.9M
Net Cash
HKD 163M
Net Cash By Market Cap
HKD 3.71
Net Cash Growth
-62.07%
Net Debt Equity
HKD -0.22
Tangible Book Value
HKD 725.5M
Tangible Book Value Per Share
HKD 3.65
WACC
0.55

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
3.7
Net Working Capital
HKD -67.7M
Quick ratio
3.54
Working Capital
HKD 356.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
1.05%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
1Y total return
0.36%
200-day SMA
23.41
50-day SMA
23.51
50-day SMA vs 200-day SMA
50over200
All Time High
42
All Time High Change
-47.43%
All Time High Date
2023-08-31
All Time Low
16.14
All Time Low Change
36.8%
All Time Low Date
2023-05-10
ATR
0.72
Beta
-0.69
Beta1y
0.09
Beta2y
0.31
Ch YTD
-6.44
High
22.08
High52
28
High52 Date
2025-08-19
High52ch
-21.14%
Low
22.08
Low52
20
Low52 Date
2025-07-17
Low52ch
10.4%
Ma50ch
-6.09%
Price vs 200-day SMA
-5.67%
RSI
40.3
RSI Monthly
46.6
RSI Weekly
44.82
Sharpe ratio
-0.05x
Sortino ratio
0.04
Total Return
1.05%
Tr YTD
-6.44
Tr1m
-3.41%
Tr1w
-4%
Tr3m
0.73%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

1
MetricValue
Operating Income
HKD -167.6M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
52,387,423%
Net Borrowing
235,516,523.7
Shares Insiders
41.75%
Shares Institutions
5.72%
Shares Out
198,913,232
Shares Qo Q
-0.74%
Shares Yo Y
-1.05%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

43
MetricValue
Adjusted FCF
HKD -210.5M
Average Volume
13,020x
Bv Per Share
3.69
CAPEX
HKD -66.9M
Ch1m
-3.41
Ch1w
-4
Ch1y
0.36
Ch3m
0.73
Ch6m
5.14
Change
0%
Change From Open
0
Close
22.08
Days Gap
0
Depreciation Amortization
30,609,697.5
Dollar Volume
26,496
Earnings Date
2026-05-26
EBIT
HKD -167.6M
EBITDA
HKD -138M
EPS
HKD -0.84
F Score
1
FCF
HKD -210.5M
FCF EV Yield
-4.98x
FCF Per Share
HKD -1.06
Financing CF
172,820,544
Fiscal Year End
December
Founded
2,001
Investing CF
-138,716,249
Is Primary Listing
1
Last Earnings Date
2026-03-18
Last Report Date
2025-12-31
Ma150
23.18
Ma150ch
-4.76%
Ma20
23.15
Ma20ch
-4.63%
Net CF
-111,213,143
Next Earnings Date
2026-05-26
Open
22.08
Ppne
677,461,088.5
Price Date
2026-05-08
Ptbv Ratio
6.05
Relative Volume
0.09x
Tr6m
5.14%
Volume
1,200
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does HKG/2480 pay a dividend?

Capital-return profile for this ticker.

Performance

HKG/2480 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+0.4%
S&P 500 1Y: n/a
3Y total return
n/a
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns HKG/2480?

Insider, institutional, and short-interest positioning.

Institutional ownership
+5.7%
Share of float held by funds and institutions
Insider ownership
+41.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-1.0%
Negative means the company is buying back shares.
Technical

HKG/2480 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
40.3
Neutral momentum band
Price vs 200-day MA
-5.7%
50/200-day relationship not available
Beta (5Y)
-0.69
Less volatile than the market
Sharpe ratio
-0.05
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About HKG/2480

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/2480 stock rating?

hkg/2480 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/2480 analysis?

The full report lives at /stocks/hkg/2480/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/2480?

The latest report frames hkg/2480 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/2480 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

hkg/2480 stock profile: metrics, valuation and analysis | AI-Agent voor de Aandelenmarkt